U.S. Pharmacist Weekly News
U.S. Pharmacist Weekly News Update
August 14, 2019

Discontinuing Statins Appears
to Be Risky for Healthy
75-Year-Olds

Pharmacists and other healthcare professionals are often pressured about unnecessary use of preventive drugs in older patients. A new study explains why the decision to discontinue shouldn’t be made lightly. Find out what happened when patients older than age 75 years stopped taking statins.

Advertisement


Real-World Study Looks at Benefits of DOACs Over Warfarin in AF Patients
Clinical guidelines recommend direct oral anticoagulants (DOACs) over warfarin for high-risk atrial fibrillation patients, but a study team sought to find out which therapy was better in real-world usage. Researchers ended up coming down on the side of DOACs. Here is what they found

Study Questions Urso Use
in Intrahepatic Cholestasis
of Pregnancy

Ursodeoxycholic acid is commonly used to treat expectant mothers who develop intrahepatic cholestasis. That might be a futile effort, however. Find out how a new study determined the therapy is ineffective and should be reconsidered.

Biologics for Psoriasis Also
Linked to Decreased
Coronary Inflammation

Not all unintended consequences are bad. Researchers were thrilled to determine that biologic therapy for severe psoriasis also significantly reduced coronary inflammation in those patients. Here is more information.

Advertisement

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement